Clinical Trial Update: Diagnostic Usefulness of Fluorine-18-α-Methyltyrosine PET in Combination With 18F-FDG in Sarcoidosis Patient

View source ↗

Summary

A completed clinical trial update examining whether combining PET imaging with Fluorine-18-α-Methyltyrosine and 18F-FDG provides diagnostic utility in a patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Drugs mentioned

• Fluorine-18-α-Methyltyrosine (18F-FAMT) (Fluorine-18-α-Methyltyrosine)
• Fluorodeoxyglucose (18F-FDG) (Fluorodeoxyglucose)

Snippet

Sponsor: Gunma University | Conditions: Sarcoidosis | Status: COMPLETED